Supply Chain/Technology

Latest Issue of OR Manager
November 2025
Home Supply Chain/Technology

ECRI issues annual list of Patient Safety Concerns

Editor's Note ECRI, on March 14, issued its annual list of Patient Safety Concerns, which is dominated this year by staffing shortages and healthcare workers’ mental health that have been made worse by the COVID-19 pandemic. In the past, the top concerns were typically associated with clinical issues caused by…

Read More

By: Judy Mathias
March 14, 2022
Share

APIC outlines actions needed to battle future pandemics while fighting rising HAIs

Editor's Note The Association for Professionals in Infection Control and Epidemiology (APIC) on March 8 announced the publication of a new report outlining actions needed to successfully battle future pandemics while fighting the rise in healthcare-associated infections (HAIs). Some recommendations in the 66-page report, titled “Between a Rock and Hard…

Read More

By: Judy Mathias
March 10, 2022
Share

FDA: Fresenius Kabi recalls Sodium Acetate Injection, USP, 400 mEq/100 mL

Editor's Note The Food and Drug Administration on March 7 posted the recall by Fresenius Kabi USA (Lake Zurich, Illinois) of seven lots of its Sodium Acetate Injection, USP, 400 mEq/100 mL The recall was initiated because of the presence of particulate matter found in reserve and/or stability sample vials.…

Read More

By: Judy Mathias
March 10, 2022
Share

FDA: Class I recall of Medtronic TurboHawk Plus Directional Atherectomy System

Editor's Note The Food and Drug Administration, on March 9, identified the recall by Medtronic of its TurboHawk Plus Directional Aherectomy System as Class I, the most serious. The recall was initiated because of the risk of the guidewire in the catheter moving downward or prolapsing when force is applied…

Read More

By: Judy Mathias
March 9, 2022
Share

Sponsored Message

Three cybersecurity companies offering free service to US hospitals

Editor's Note OR Manager recently reported on the increased cybersecurity risk the Russia/Ukraine conflict poses to US healthcare systems. With two new malware threats identified last week, the Cybersecurity and Infrastructure Security Agency and the FBI are urging US organizations and the private sector, including healthcare, to stay vigilant and…

Read More

By: Tarsilla Moura
March 8, 2022
Share

FDA: B. Braun Medical recalls 0.9% Sodium Chloride for Injection USP 250 ml in Excel

Editor's Note The Food and Drug Administration (FDA) on March 3 posted the recall by B. Braun Medical Inc of its nationwide recall of five lots of 0.9% Sodium Chloride for Injection USP 250 ml in Excel. The recall was initiated because of fluid leakage or low fill volume of…

Read More

By: Judy Mathias
March 8, 2022
Share

Sponsored Message

Cybersecurity alert: Two new malware threats identified, increased risk

Editor's Note On February 23, the American Hospital Association (AHA) released a Cybersecurity Advisory report because of the heightened risk of cyberattacks due to the current Russia-Ukraine conflict. According to AHA, just this past weekend, the Cybersecurity and Infrastructure Security Agency and the FBI urged the US private sector, including…

Read More

By: Tarsilla Moura
March 1, 2022
Share

FDA: Class I recall of Arrow International’s Arrow-Trerotola PTD

Editor's Note The Food and Drug Administration (FDA) on February 23 identified the recall by Arrow International (Reading, Pennsylvania), a subsidiary of Teleflex Inc, of its Arrow-Trerotola Percutaneous Thrombolytic Device (PTD) as Class I, the most serious. The recall was initiated because of the risk of tip damage during use…

Read More

By: Judy Mathias
February 24, 2022
Share

FDA: Class I recall of Vyaire Medical’s Bellavista Ventilators

Editor's Note The Food and Drug Administration (FDA) on February 17 identified the recall by Vyaire Medical (Mettawa, Illinois) of its Bellavista 1000 and 1000e Series Ventilators as Class I, the most serious. The recall was initiated because of issues with the software version 6.0.1600.0 or higher, after reports of…

Read More

By: Judy Mathias
February 24, 2022
Share

FDA: Class I recall of BASE10 Genetics RNAstill MTM specimen collection kits

Editor's Note The Food and Drug Administration (FDA) on February 18 identified the recall by BASE10 Genetics of its RNAstill MTM specimen collection kits as Class I, the most serious. The specimen collection kits are intended for collection, transport, inactivation, stabilization, and long-term storage of nasopharyngeal or oropharyngeal swab samples…

Read More

By: Judy Mathias
February 23, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat